Roivant Sciences Ltd.
ROIV
71 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Sep 22 8:20 PM | ERIC VENKER | Proposed Sale | 316,182 | $14.99 | $4.7M | — | View → |
| Sep 22, 2025 | Sep 22 8:07 PM | Venker Eric | Proposed Sale | 100,000 | $15.01 | $1.5M | — | View → |
| Sep 19, 2025 | Sep 19 8:32 PM | ERIC VENKER | Proposed Sale | 683,818 | $14.95 | $10.2M | — | View → |
| Aug 20, 2025 | Aug 20 8:30 PM | Venker Eric | Proposed Sale | 100,000 | $11.72 | $1.2M | — | View → |
| Jul 21, 2025 | Jul 21 8:34 PM | Venker Eric | Proposed Sale | 100,000 | $11.52 | $1.2M | — | View → |
| Jun 20, 2025 | Jun 20 8:35 PM | Ramaswamy Vivek | Proposed Sale | 577,007 | $11.46 | $6.6M | — | View → |
| Jun 20, 2025 | Jun 20 8:13 PM | Venker Eric | Proposed Sale | 100,000 | $11.45 | $1.1M | — | View → |
| Jun 18, 2025 | Jun 18 8:38 PM | Ramaswamy Vivek | Proposed Sale | 565,266 | $11.45 | $6.5M | — | View → |
| Jun 6, 2025 | Jun 6 8:33 PM | Ramaswamy Vivek | Proposed Sale | 200,800 | $11.19 | $2.2M | — | View → |
| Jun 4, 2025 | Jun 4 8:42 PM | Ramaswamy Vivek | Proposed Sale | 547,430 | $11.34 | $6.2M | — | View → |
| Jun 3, 2025 | Jun 3 9:14 PM | ERIC VENKER | Proposed Sale | 566,278 | $11.22 | $6.4M | — | View → |
| Jun 2, 2025 | Jun 2 8:16 PM | ERIC VENKER | Proposed Sale | 433,722 | $11.07 | $4.8M | — | View → |
| May 20, 2025 | May 20 8:30 PM | Venker Eric | Proposed Sale | 100,000 | $10.95 | $1.1M | — | View → |
| May 7, 2025 | May 7 8:37 PM | Ramaswamy Vivek | Proposed Sale | 625,000 | $11.18 | $7.0M | — | View → |
| May 6, 2025 | May 6 8:21 PM | Ramaswamy Vivek | Proposed Sale | 273,959 | $11.47 | $3.1M | — | View → |
| Apr 21, 2025 | Apr 21 7:22 PM | Venker Eric | Proposed Sale | 100,000 | $10.22 | $1.0M | — | View → |
| Mar 20, 2025 | Mar 20 9:27 PM | Venker Eric | Proposed Sale | 650,000 | $10.95 | $7.1M | — | View → |
| Mar 20, 2025 | Mar 20 7:54 PM | Venker Eric | Proposed Sale | 100,000 | $11.11 | $1.1M | — | View → |
| Feb 20, 2025 | Feb 20 8:35 PM | Venker Eric | Proposed Sale | 100,000 | $10.65 | $1.1M | — | View → |
| Feb 13, 2025 | Feb 18 5:15 PM | Kumar Rakhi | Proposed Sale | 227,500 | $10.43 | $2.4M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 5 10:05 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 151,416(D) | View → |
| Sep 30, 2026 | Oct 2 9:37 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,644,834(D) | View → |
| Sep 16, 2026 | Sep 19 1:00 AM | Keith S ManchesterDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:12 PM | Daniel Allen GoldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:06 PM | Ilan OrenDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:01 PM | James C MomtazeeDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:57 PM | Meghan FitzgeraldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:56 PM | Melissa B, EpperlyDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 8, 2026 | Sep 11 1:00 AM | Meghan FitzgeraldDirector | Option Exercise | 20,000 | $8.80 | 18,578(D) | View → |
| Aug 28, 2026 | Sep 2 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,844,834(D) | View → |
| Aug 21, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 144,756 | $3.85 | 13,224,363(D) | View → |
| Aug 20, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 17,519 | $3.85 | 13,369,119(D) | View → |
| Aug 19, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 172,899 | $3.85 | 13,386,638(D) | View → |
| Aug 18, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 136,942 | $3.85 | 13,559,537(D) | View → |
| Aug 17, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 284,707 | $3.85 | 13,696,479(D) | View → |
| Aug 14, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 243,177 | $3.85 | 13,981,186(D) | View → |
| Jul 27, 2026 | Jul 30 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,044,834(D) | View → |
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
Page 1 of 2
Next →